EUVIMEDEUVIMED entdecken
Crossref

The Clinical Use of Stem Cells in Liver Cancer Treatment: Interactions Between Diet, Metabolic Disease and Hepatic Regeneration

Julia Coelho Moura, Vincent S Gallicchio

Journal of Regenerative Medicine and Biology Research · 05.06.2026 · 7 (2) · 1-10

DOI: 10.46889/jrmbr.2026.7204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Regenerative Medicine and Biology Research, online erschienen am 05.06.2026. Verfasst von Julia Coelho Moura und 1 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular Carcinoma (HCC) is the most frequent primary liver cancer and a leading cause of cancer-related death globally. HCC typically develops in the presence of chronic liver disease, such as cirrhosis, Non-Alcoholic Fatty Liver Disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Underlying liver damage limits treatment options and contributes to poor clinical outcomes. This review examines the pathophysiological progression from NAFLD and NASH to cirrhosis and ultimately HCC, with emphasis on insulin resistance, chronic inflammation, oxidative stress and fibrosis. These interrelated pathways accelerate disease progression and create conditions conducive to tumor formation while reducing the liver’s ability to repair itself. It also explores the therapeutic potential of stem cell-based treatments, including induced pluripotent stem cells (iPSCs), hepatic progenitor cells and mesenchymal stem cells (MSCs). These therapies have been studied for their ability to reduce inflammation, promote tissue regeneration and improve liver function in patients with chronic liver disease and HCC. Although early clinical trials show encouraging outcomes, long-term safety concerns and variability in treatment protocols remain challenges. Recent research highlights how dietary and metabolic factors influence disease progression and treatment effectiveness. Dietary patterns affect key processes, including immune activation and lipid metabolism, thereby impacting both liver injury and regenerative capacity. These findings suggest that nutrition is a modifiable factor influencing disease progression and therapeutic response. Overall, stem cell-based therapies may provide benefits as adjuncts to existing treatments, but their effectiveness is influenced by the metabolic context in which they are used.

Zitieren

APA

Moura, J. C., & Gallicchio, V. S. (2026). The Clinical Use of Stem Cells in Liver Cancer Treatment: Interactions Between Diet, Metabolic Disease and Hepatic Regeneration. Journal of Regenerative Medicine and Biology Research, 7(2), 1-10. https://doi.org/10.46889/jrmbr.2026.7204

Vancouver

Moura JC, Gallicchio VS. The Clinical Use of Stem Cells in Liver Cancer Treatment: Interactions Between Diet, Metabolic Disease and Hepatic Regeneration. Journal of Regenerative Medicine and Biology Research. 2026;7(2):1-10. doi:10.46889/jrmbr.2026.7204

BibTeX
@article{Moura2026,
  author = {Moura, Julia Coelho and Gallicchio, Vincent S},
  title = {The Clinical Use of Stem Cells in Liver Cancer Treatment: Interactions Between Diet, Metabolic Disease and Hepatic Regeneration},
  journal = {Journal of Regenerative Medicine and Biology Research},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {1--10},
  doi = {10.46889/jrmbr.2026.7204}
}
Kostenlos starten →